Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
57.80
+1.36 (2.41%)
Jun 27, 2025, 4:00 PM - Market closed

Utah Medical Products Market Cap

Utah Medical Products has a market cap or net worth of $187.75 million as of June 27, 2025. Its market cap has decreased by -21.25% in one year.

Market Cap
187.75M
Enterprise Value
101.15M
1-Year Change
-21.25%
Ranking
Category
Stock Price
$57.80

Market Cap Chart

Since March 8, 1999, Utah Medical Products's market cap has increased from $49.30M to $187.75M, an increase of 280.82%. That is a compound annual growth rate of 5.21%.

History

DateMarket Cap% Change
Jun 27, 2025187.70M-9.98%
Dec 31, 2024208.50M-31.80%
Dec 29, 2023305.70M-16.18%
Dec 30, 2022364.70M-0.11%
Dec 31, 2021365.10M18.96%
Dec 31, 2020306.90M-23.56%
Dec 31, 2019401.50M29.43%
Dec 31, 2018310.20M2.41%
Dec 29, 2017302.90M10.71%
Dec 30, 2016273.60M24.65%
Dec 31, 2015219.50M-2.36%
Dec 31, 2014224.80M5.15%
Dec 31, 2013213.80M60.99%
Dec 31, 2012132.80M35.10%
Dec 30, 201198.30M1.13%
Dec 31, 201097.20M-8.13%
Dec 31, 2009105.80M25.95%
Dec 31, 200884.00M-27.84%
Dec 31, 2007116.40M-10.67%
Dec 29, 2006130.30M5.59%
Dec 30, 2005123.40M33.55%
Dec 31, 200492.40M-23.38%
Dec 31, 2003120.60M28.30%
Dec 31, 200294.00M37.43%
Dec 31, 200168.40M81.43%
View and export this data all the way back to 1999. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 713.81B
Johnson & Johnson 365.75B
AbbVie 329.95B
Novo Nordisk 299.93B
UnitedHealth Group 274.52B
Novartis AG 235.02B
Abbott Laboratories 232.56B
AstraZeneca 215.99B
Market Cap Rankings